Correlation Between HeartCore Enterprises and Quoin Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both HeartCore Enterprises and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HeartCore Enterprises and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HeartCore Enterprises and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on HeartCore Enterprises and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HeartCore Enterprises with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HeartCore Enterprises and Quoin Pharmaceuticals.

Diversification Opportunities for HeartCore Enterprises and Quoin Pharmaceuticals

0.18

Correlation Coefficient

HeartCore Enterprises  Quoin Pharmaceuticals

Average diversification

The 3 months correlation between HeartCore and Quoin is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding HeartCore Enterprises and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and HeartCore Enterprises is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HeartCore Enterprises are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of HeartCore Enterprises i.e., HeartCore Enterprises and Quoin Pharmaceuticals go up and down completely randomly.

Pair Corralation between HeartCore Enterprises and Quoin Pharmaceuticals

Given the investment horizon of 90 days HeartCore Enterprises is expected to generate 0.64 times more return on investment than Quoin Pharmaceuticals. However, HeartCore Enterprises is 1.56 times less risky than Quoin Pharmaceuticals. It trades about 0.27 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about 0.01 per unit of risk. If you would invest  62.00  in HeartCore Enterprises on September 4, 2024 and sell it today you would earn a total of  110.00  from holding HeartCore Enterprises or generate 177.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

HeartCore Enterprises  vs.  Quoin Pharmaceuticals Ltd

HeartCore Enterprises

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in HeartCore Enterprises are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, HeartCore Enterprises reported solid returns over the last few months and may actually be approaching a breakup point.

Quoin Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly conflicting basic indicators, Quoin Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with HeartCore Enterprises and Quoin Pharmaceuticals

The main advantage of trading using opposite HeartCore Enterprises and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HeartCore Enterprises position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.

The idea behind HeartCore Enterprises and Quoin Pharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.